generic glp 1 medication FDA Approves First GLP-1 Weight Loss Drug Diabetes patients now have access
Description
Semaglutide vs Tirzepatide: What a Clinician Evaluates Both semaglutide and tirzepatide are GLP-1 receptor agonists-a class of medications originally developed for type 2 diabetes that have shown significant effects on weight loss in clinical trials
After using these tools, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication
doi:10.1038/s41392-024-01951-9 Uusitupa M, Khan TA, Viguiliouk E, et al
Ida S, Kaneko R, Imataka K, Okubo K, Shirakura Y, Azuma K, et al
The average age was 54, and the average body mass index (BMI) was 35.5
